REGN4461

· Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for REGN4461, covering 2025-02-25 to 2026-03-12. Get the full timeline:

Most recent: Clinical Trial Update: Expanded Access to REGN4461 for Patients With Diseases Associated With Deficient Leptin Signaling